Sensei Biotherapeutics Inc

General ticker "SNSE" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $12.2M

Sensei Biotherapeutics Inc does not follow the US Stock Market performance with the rate: -25.4%.

Estimated limits based on current volatility of 4.8%: low 0.43$, high 0.47$

Factors to consider:

  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.48$, 1.40$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.66$, 1.77$]

Financial Metrics affecting the SNSE estimates:

  • Negative: Non-GAAP EPS, $ of -1.22 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -63.24 <= 2.35
  • Negative: negative Net income
  • Positive: Interest expense per share, $ of 0.01 <= 0.14
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85

Similar symbols

Short-term SNSE quotes

Long-term SNSE plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $37.48MM $50.19MM $37.06MM
Operating Income $-37.48MM $-50.19MM $-37.06MM
Non-Operating Income $0.69MM $1.60MM $2.96MM
Interest Expense $0.67MM $0.22MM $0.14MM
R&D Expense $21.66MM $30.38MM $18.30MM
Income(Loss) $-36.79MM $-48.59MM $-34.10MM
Profit(Loss) $-36.79MM $-48.59MM $-34.10MM
Stockholders Equity $146.51MM $103.41MM $64.89MM
Assets $153.22MM $118.38MM $74.37MM
Operating Cash Flow $-30.26MM $-39.03MM $-32.02MM
Capital expenditure $2.03MM $0.32MM $0.18MM
Investing Cash Flow $-143.12MM $49.95MM $38.41MM
Financing Cash Flow $163.94MM $-0.29MM $-11.17MM
Earnings Per Share* $-1.35 $-1.59 $-1.22

* EPS are Split Adjusted, recent splits may be reflected with a delay.